172 related articles for article (PubMed ID: 11845477)
1. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Poiată A; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
[TBL] [Abstract][Full Text] [Related]
2. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
Tayfour M; Yuce A; Yulug N
Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
[TBL] [Abstract][Full Text] [Related]
4. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
5. The antimicrobial susceptibility of Escherichia coli isolated in eastern area of Romania. A surveillance study.
Poiată A; Tuchilus C; Bădicut I; Grigore L; Filipiuc S; Adomniţei C; Buiuc D
Roum Arch Microbiol Immunol; 1999; 58(2):177-84. PubMed ID: 11845455
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
[TBL] [Abstract][Full Text] [Related]
7. Resistance to quinolones in pathogens causing urinary tract infections.
Kapoor H; Aggarwal P
J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
[TBL] [Abstract][Full Text] [Related]
8. [Resistant mutant prevention concentration of fluoroquinolones in clinical isolates of extended spectrum beta-lactamase (ESBL) producing and non-producing strains of Escherichia coli].
Noguera O; Rodríguez JC; López JM; Ruiz M; Royo G
Rev Esp Quimioter; 2009 Mar; 22(1):30-3. PubMed ID: 19308744
[TBL] [Abstract][Full Text] [Related]
9. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of quinolone resistance in Escherichia coli from wild birds.
Jiménez Gómez PA; García de los Rios JE; Rojas Mendoza A; de Pedro Ramonet P; García Albiach R; Reche Sainz MP
Can J Vet Res; 2004 Jul; 68(3):229-31. PubMed ID: 15352551
[TBL] [Abstract][Full Text] [Related]
11. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
Zafar A; Ibrahim NG; Ahsan T; Abbas Z; Zaidi A; Hasan R
J Coll Physicians Surg Pak; 2005 Jul; 15(7):413-7. PubMed ID: 16197870
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
13. Mercury resistance among clinical isolates of Escherichia coli.
Poiată A; Bădicuţ I; Indreş M; Biro M; Buiuc D
Roum Arch Microbiol Immunol; 2000; 59(1-2):71-9. PubMed ID: 11845478
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
[TBL] [Abstract][Full Text] [Related]
15. A high incidence of ciprofloxacin resistance in urinary isolates in eastern Nepal.
Srinivasa H; Parija SC; Bhattacharya S; Sehgal R
J Commun Dis; 1999 Mar; 31(1):45-7. PubMed ID: 10810586
[TBL] [Abstract][Full Text] [Related]
16. [Distribution and diversity of conjugative plasmids among some multiple antibiotic resistant E.coli strains isolated from river waters].
Cernat R; Lazăr V; Balotescu C; Cotar A; Coipan E; Cojocaru C
Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):147-53. PubMed ID: 15085604
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].
Coban AY; Birinci A; Ekinci B; Durupinar B
Mikrobiyol Bul; 2004; 38(1-2):21-5. PubMed ID: 15293898
[TBL] [Abstract][Full Text] [Related]
18. [Study on the accumulation of fluoroquinolones in clinical isolates of susceptible and multi-drug-resistant Escherichia coli strains].
Fang ZP; Xu W; Liu XK; Song XH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):86-9. PubMed ID: 15702790
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
[TBL] [Abstract][Full Text] [Related]
20. Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model.
Mahamat A; Lavigne JP; Fabbro-Peray P; Kinowski JM; Daurès JP; Sotto A
Clin Microbiol Infect; 2005 Apr; 11(4):301-6. PubMed ID: 15760427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
